Catalyst
Slingshot members are tracking this event:
PDUFA date May 1 2016 of NUPLAZID (Pimavanserin) for Parkinson's disease psychosis (PDP) - under priority review
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ACAD | Community voting in process |
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 29, 2016
Occurred Source:
http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-newsArticle&ID=2163521
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pdufa, Pimavanserin, Parkinson's Disease Psychosis, Priority Review, Priority Review Designation